1. Home
  2. NPKI vs KROS Comparison

NPKI vs KROS Comparison

Compare NPKI & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

N/A

Current Price

$13.17

Market Cap

1.2B

Sector

Industrials

ML Signal

N/A

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

N/A

Current Price

$10.85

Market Cap

584.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NPKI
KROS
Founded
1932
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
584.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NPKI
KROS
Price
$13.17
$10.85
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
$14.17
$22.25
AVG Volume (30 Days)
748.2K
359.4K
Earning Date
01-01-0001
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.00
EPS
N/A
2.30
Revenue
N/A
$243,864,000.00
Revenue This Year
$14.60
N/A
Revenue Next Year
$12.80
N/A
P/E Ratio
$38.65
$4.90
Revenue Growth
N/A
N/A
52 Week Low
$4.76
$9.12
52 Week High
$15.85
$22.55

Technical Indicators

Market Signals
Indicator
NPKI
KROS
Relative Strength Index (RSI) 39.53 17.11
Support Level $11.89 N/A
Resistance Level $13.25 $15.21
Average True Range (ATR) 0.66 0.73
MACD -0.14 -0.27
Stochastic Oscillator 4.07 6.95

Price Performance

Historical Comparison
NPKI
KROS

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: